Case report: Long-term survival with anlotinib in a metastatic parathyroid carcinoma patient harboring EGFR-sensitizing mutation

Abstract excerpt

<title>Abstract</title> <p>Parathyroid carcinoma (PC) is a rare and aggressive endocrine malignancy with limited treatment options. Despite the lack of standard management approaches to prevent recurrence and metastasis, current treatments such as chemotherapy and radiotherapy have demonstrated limited efficacy. Here, we report the case of a 54-year-old male patient who presented with a range of symptoms includin...

Topics

Open a Topic to create a Post that cites this publication.

• Carcinoma
• ErbB Receptors
• Lung Neoplasms
• Medical Imaging and Pathology Studies
• Mutation
• Neoplasm Recurrence, Local
• Parathyroid Disorders and Treatments
• Parathyroid Neoplasms

Identifiers and source

Literature Corpus work

08787c3e-a241-53b0-9a32-c78f865bf8b8

DOI

10.21203/rs.3.rs-3141396/v1